Article Text

PDF

PS-131 Hemolysis In Neonatal Piglets Receiving Centrifugal-pump Extracorporal Respiratory Support: An In-vivo Comparative Bench Study
  1. S Herber-Jonat1,
  2. K Lüninghöner2,
  3. J Ngonak1,
  4. A Schulze1,
  5. AW Flemmer1
  1. 1Neonatology Perinatal Centre Großhadern, Dr Von Hauner Childrens´ Hospital LMU Munich, Munich, Germany
  2. 2Department of Anaesthesiology, University Hospital Munich, Munich, Germany

Abstract

Background The challenge of non-cardiac, neonatal extracorporal membrane oxygenation (ECMO) is the need for miniaturised circuits, small cannulas and low flow rates. Novel small rotating pump devices with diagonal blood flow have a reduced priming volume and circuit surface area. Bench studies in different in-vitro models are encouraging. However, little data exist on hemolysis, coagulation and fibrinolysis in defined in-vivo models.

Setting Twelve newborn piglets were randomly assigned to receive either veno-arterial ECMO with a novel diagonal pump system or to serve as controls. The ECMO circuit was prefilled with 70 ml packed red blood cells from adult swine. Blood was drained through 8 Fr venous and reinfused through 6 Fr arterial cannulas. ECMO was applied on 75% total cardiac output (80–100 ml/kg). The effect of the diagonal pump system on required circuit settings, heparin-use, plasma-free haemoglobin (fHb), lactatdehydrogenase and coagulation/fibsinolysis were studied.

Results Mild hemolysis was diagnosed within the first hour in all ECMO-piglets [mean fHb 49.7 mg/dl [9.0; 90.3; 95% CI]. After 8 hrs on ECMO mean fHb decreased, but was still significantly higher as compared to controls (25.5 mg/dl [8.7; 42.5] vs 4.7 mg/dl [0.8; 8.6], p = 0.02). Median mean flow rate, venous inlet pressure, and revolutions per hour were 222 ml/min (197; 313, Range), -20 cm H2O (-36; -6), and 5295 rpm (4906; 6816) respectively. Fibrin degradation products and fibrinogen levels remained normal in ECMO and control piglets throughout the study period.

Conclusion The use of a novel diagonal pump system for ECMO in our in-vivo model generates a comparable amount of fHb as previously observed under in-vitro conditions.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.